INM
Price
$2.87
Change
-$0.29 (-9.18%)
Updated
Jun 6 closing price
Capitalization
3.86M
SPHDF
Price
$14.75
Change
-$1.15 (-7.23%)
Updated
May 28 closing price
Capitalization
205.41M
Interact to see
Advertisement

INM vs SPHDF

Header iconINM vs SPHDF Comparison
Open Charts INM vs SPHDFBanner chart's image
InMed Pharmaceuticals
Price$2.87
Change-$0.29 (-9.18%)
Volume$208.32K
Capitalization3.86M
Santhera Pharmaceuticals Holdings
Price$14.75
Change-$1.15 (-7.23%)
Volume$285
Capitalization205.41M
INM vs SPHDF Comparison Chart
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. SPHDF commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a StrongBuy and SPHDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (INM: $2.63 vs. SPHDF: $14.75)
Brand notoriety: INM and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 25% vs. SPHDF: 178%
Market capitalization -- INM: $3.86M vs. SPHDF: $205.41M
INM [@Biotechnology] is valued at $3.86M. SPHDF’s [@Biotechnology] market capitalization is $205.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 1 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHDF is a better buy in the long-term than INM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 6 TA indicator(s) are bullish.

  • INM’s TA Score: 6 bullish, 3 bearish.

Price Growth

INM (@Biotechnology) experienced а -2.59% price change this week, while SPHDF (@Biotechnology) price change was -15.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPHDF($205M) has a higher market cap than INM($3.86M). SPHDF has higher P/E ratio than INM: SPHDF (2.52) vs INM (0.01). SPHDF YTD gains are higher at: 56.582 vs. INM (-42.702).
INMSPHDFINM / SPHDF
Capitalization3.86M205M2%
EBITDA-7.44MN/A-
Gain YTD-42.70256.582-75%
P/E Ratio0.012.521%
Revenue4.83MN/A-
Total Cash3.42MN/A-
Total Debt949KN/A-
FUNDAMENTALS RATINGS
INM vs SPHDF: Fundamental Ratings
INM
SPHDF
OUTLOOK RATING
1..100
8995
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8439
P/E GROWTH RATING
1..100
8112
SEASONALITY SCORE
1..100
5032

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INM's Valuation (38) in the null industry is in the same range as SPHDF (62). This means that INM’s stock grew similarly to SPHDF’s over the last 12 months.

INM's Profit vs Risk Rating (100) in the null industry is in the same range as SPHDF (100). This means that INM’s stock grew similarly to SPHDF’s over the last 12 months.

INM's SMR Rating (98) in the null industry is in the same range as SPHDF (100). This means that INM’s stock grew similarly to SPHDF’s over the last 12 months.

SPHDF's Price Growth Rating (39) in the null industry is somewhat better than the same rating for INM (84). This means that SPHDF’s stock grew somewhat faster than INM’s over the last 12 months.

SPHDF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for INM (81). This means that SPHDF’s stock grew significantly faster than INM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INM
RSI
ODDS (%)
Bullish Trend 12 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with OMER. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-5.40%
OMER - INM
46%
Loosely correlated
-0.95%
TTNP - INM
44%
Loosely correlated
-0.65%
SPHDF - INM
33%
Poorly correlated
-7.23%
XFOR - INM
32%
Poorly correlated
-4.13%
SQZB - INM
29%
Poorly correlated
N/A
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with GYRE. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then GYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
-7.23%
GYRE - SPHDF
82%
Closely correlated
-7.27%
HRMY - SPHDF
37%
Loosely correlated
-0.21%
SPRC - SPHDF
34%
Loosely correlated
+2.32%
INM - SPHDF
33%
Poorly correlated
-5.40%
RVMD - SPHDF
33%
Poorly correlated
+2.04%
More